| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. (MCRB) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. MCRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 56.3K | $371.3K | - | |
| Other | 22.5K | $148.5K | - | |
| Dir | 11.5K | $75.7K | - | |
| Dir | 11.0K | $72.6K | - | |
| Dir | 10.0K | $66.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2018 | Pomerantz Roger | President And CEO | Sale+OE | 1,010 | $9.01 | $9,098.99 | -0.4% | |
| Jul 10, 2018 | Pomerantz Roger | President And CEO | Sale+OE | 32,336 | $9.12 | $295,065.31 | -4.5% | |
| Jun 29, 2018 | Pomerantz Roger | President And CEO | Sale+OE | 26,056 | $9.15 | $238,290.73 | -5.4% | |
| Jun 27, 2018 | Pomerantz Roger | President And CEO | Sale+OE | 64,967 | $9.16 | $595,045.43 | -8.7% | |
| Jun 22, 2018 | Pomerantz Roger | President And CEO | Sell | 85,536 | $9.28 | $793,906.79 | -9.5% | |
| Jun 15, 2018 | Aunins John G. | Chief Technology Officer &EVP | Sell | 14,279 | $8.57 | $122,325.34 | -7.7% | |
| May 9, 2018 | Pomerantz Roger | President And CEO | Sell | 233 | $9.00 | $2,097.00 | - | |
| Apr 25, 2018 | Aunins John G. | Chief Technology Officer &EVP | Sell | 14,279 | $7.58 | $108,266.23 | -7.2% | |
| Jan 26, 2018 | Trucksis Michele | See Remarks | Sale+OE | 2,607 | $11.02 | $28,729.14 | -34.8% | |
| Jan 26, 2018 | Aunins John G. | See Remarks | Sale+OE | 1,738 | $11.02 | $19,152.76 | -0.9% |